Agency abruptly withdraws plan to require standardized asbestos testing • Move contradicts congressional mandate in 2022 ...
As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having ...
The U.S. Food and Drug Administration on Tuesday extended its review of Ascendis Pharma's therapy for children with a rare ...
MedPage Today on MSN
FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease
The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...
Boar’s Head Grated Pecorino Romano Cheese, Locatelli Pecorino Romano Grated Cheese and wedges of Boar's Head Pecorino Romano ...
The FDA has approved durvalumab (Imfinzi) plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for the treatment ...
The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...
KSHB 41 News reporter Isabella Ledonne's Strong High Weak Laws series continues to amplify the community's concerns about ...
See the full November 2025 FDA recalls list, including Boar's Head Chicken Caesar Salad, Haagen-Dazs bars, baby formula and ...
The change removes several major safety notices from common hormone products, but doctors say decisions should remain ...
The Trump administration is withdrawing a proposal to require cosmetic companies to test their talc-containing products for ...
Novartis is pricing Itvisma at a wholesale acquisition cost of $2.59 million, a company spokesperson told Fierce Pharma. At ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback